Pharmaceutical Industry Applauds Determination to End Animal Extremism, UK
The additional proposals as part of the Serious & Organised Crime Bill directly address what the ABPI has called for. The Association believes this legislation will deal with the intimidatory and threatening activities of animal extremists faced by researchers.
?The ABPI welcomes this confirmation of the Government\'s determination to deal with the extremists and pharmaceutical companies will see this as a watershed not just in terms of removing a key concern about further investment in to the UK, but also in the drive to develop new medicines for patients,? said ABPI Director General Dr Richard Barker.
ABPI Director of Science & Technology, Dr Philip Wright added: ?Since the announcement of further government action on this issue in July, the Government has listened carefully to all stakeholders affected by animal rights extremism.
?No one wishes to curb those who wish to make legitimate, peaceful protest within the law, but the activities of animal extremists have descended into a pattern of harassment, intimidation and violence that cannot be tolerated in a civilised society.?
Note to Editors
For further information, please contact:
Richard Ley (office) 020 7747 1410 (home) 020 8866 4622 mobile 07715 169727
Ben Hayes (office) 020 7747 1406 (home) 020 8959 7830 mobile 07715 169726
This is a press release from the ABPI
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Nordqvist, Christian. "Pharmaceutical Industry Applauds Determination to End Animal Extremism, UK." Medical News Today. MediLexicon, Intl., 31 Jan. 2005. Web.
28 Jun. 2017. <http://www.medicalnewstoday.com/releases/19450.php>
Nordqvist, C. (2005, January 31). "Pharmaceutical Industry Applauds Determination to End Animal Extremism, UK." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.